Gideon M Blumenthal

Challenges with Novel Clinical Trial Designs: Master Protocols

Michael Cecchini, Hildy Dillon, P. LoRusso, 2019, Clinical Cancer Research.

FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy

Anuradha Ramamoorthy, Richard Pazdur, Kaushalkumar Dave, 2018, Clinical Cancer Research.

FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer

Sean Khozin, Ping Zhao, Richard Pazdur, 2015, Clinical Cancer Research.

A Benefit–Risk Analysis Approach to Capture Regulatory Decision‐Making: Multiple Myeloma

G. K. Raju, Richard Pazdur, Janet Woodcock, 2018, Clinical pharmacology and therapeutics.

Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.

J. LoPiccolo, P. Dennis, G. Blumenthal, 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

David Wholley, Jeffrey D Bradley, Dana Sparks, 2015, Clinical Cancer Research.

Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses.

Sean Khozin, Hui Zhang, Richard Pazdur, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.